Evidence map›Paper›PMID 29476054›Full record

ArticleNature communications2018

Membrane cholesterol mediates the cellular effects of monolayer graphene substrates.

Kristina E Kitko, Tu Hong, Roman M Lazarenko, Da Ying, Ya-Qiong Xu, Qi Zhang

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review of methods for the determination of cellular cholesterol content: principles, advantages, limitations, applications, and perspectives.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Recent progresses in novelFrontiers in bioengineering and biotechnology · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. 2D materials in electrochemical sensors for in vitro or in vivo use.Analytical and bioanalytical chemistry · 2021
    Review
  14. Nanoscale advances · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kristina E KitkoDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.
Tu HongDepartment of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, 37235, USA.
Roman M LazarenkoDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA.ORCID http://orcid.org/0000-0003-0177-2961
Da YingDepartment of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, 37235, USA.
Ya-Qiong XuProgram in Interdisciplinary Materials Science, Vanderbilt University, Nashville, TN, 37235, USA.
Qi ZhangDepartment of Pharmacology, Vanderbilt University, Nashville, TN, 37232, USA. qi.zhang@vanderbilt.edu.
Vanderbilt University · US

Funding

Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Modulation of Synaptic Vesicles in Neurotransmission, Plasticity and AddictionR00DA025143 · NIDA · VANDERBILT UNIVERSITY · PI ZHANG, QI · 2010 to 2012
$729k
O Brother, Where Art Thou - Interrogating Glutamate Co-transmission in Dopaminergic Neurons at Single-vesicle Level using Cell Reprograming and CRISPRR21NS094738 · NINDS · VANDERBILT UNIVERSITY · PI ZHANG, QI · 2016 to 2017
$431k
Modulation of Synaptic Vesicles in Neurotransmission, Plasticity and AddictionK99DA025143 · NIDA · STANFORD UNIVERSITY · PI ZHANG, QI · 2009 to 2010
$273k
NICHD NIH HHS U54 HD083211NIDA NIH HHS K99 DA025143NIDA NIH HHS R00 DA025143NINDS NIH HHS R21 NS094738
6 · The paper itself

Abstract

Graphene possesses extraordinary properties that promise great potential in biomedicine. However, fully leveraging these properties requires close contact with the cell surface, raising the concern of unexpected biological consequences. Computational models have demonstrated that graphene preferentially interacts with cholesterol, a multifunctional lipid unique to eukaryotic membranes. Here we demonstrate an interaction between graphene and cholesterol. We find that graphene increases cell membrane cholesterol and potentiates neurotransmission, which is mediated by increases in the number, release probability, and recycling rate of synaptic vesicles. In fibroblasts grown on graphene, we also find an increase in cholesterol, which promotes the activation of P2Y receptors, a family of receptor regulated by cholesterol. In both cases, direct manipulation of cholesterol levels elucidates that a graphene-induced cholesterol increase underlies the observed potentiation of each cell signaling pathway. These findings identify cholesterol as a mediator of graphene's cellular effects, providing insight into the biological impact of graphene.

Indexed as

AnimalsCell MembraneCholesterolElectrophysiologyFemaleFibroblastsGraphiteMaleMiceNeuronsNIH 3T3 CellsRatsRats, Sprague-DawleyReceptors, Purinergic P2YCholesterolGraphiteReceptors, Purinergic P2Y

Identifiers

PMID29476054
PMCPMC5824811
OpenAlexW2794914578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.